Skip to content
10-Q/A

Quarterly Report

ENDONOVO THERAPEUTICS, INC. ENDV

0001493152-23-046561

← back to feed
Filed
Dec 29, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Dec 28, 2023 318.75M sh
Shares Diluted Q3 2023 · Sep 30, 2023 1.35B sh
Shares Diluted Q3 2023 · Sep 30, 2023 1.35B sh
Shares Diluted Q3 2023 · Sep 30, 2022 153.6M sh
Shares Diluted Q3 2023 · Sep 30, 2022 122.54M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$404.36K
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$453.3K
Long Term Debt Q3 2023 · Sep 30, 2023 $7.09M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $0
Cash And Equivalents Q3 2023 · Dec 31, 2022 $98
Stockholders Equity Q3 2023 · Sep 30, 2023 −$22.96M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$22.41M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$24.37M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$32.18M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$19.61M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$19.16M
Stockholders Equity Q3 2023 · Mar 31, 2022 −$18.04M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$15.77M
Current Liabilities Q3 2023 · Sep 30, 2023 $23.7M
Current Liabilities Q3 2023 · Dec 31, 2022 $33.38M
Total Liabilities Q3 2023 · Sep 30, 2023 $23.78M
Total Liabilities Q3 2023 · Dec 31, 2022 $33.46M
Current Assets Q3 2023 · Sep 30, 2023 $35.5K
Current Assets Q3 2023 · Dec 31, 2022 $15.82K
Total Assets Q3 2023 · Sep 30, 2023 $815.76K
Total Assets Q3 2023 · Dec 31, 2022 $1.28M
Eps Diluted Q3 2023 · Sep 30, 2023 $0.00
Eps Diluted Q3 2023 · Sep 30, 2023 $0.00
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.05
Eps Basic Q3 2023 · Sep 30, 2023 −$0.00
Eps Basic Q3 2023 · Sep 30, 2023 $0.03
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 −$0.05
Net Income Q3 2023 · Sep 30, 2023 −$766.17K
Net Income Q3 2023 · Sep 30, 2023 $8.53M
Net Income Q3 2023 · Jun 30, 2023 $2.06M
Net Income Q3 2023 · Mar 31, 2023 $7.23M
Net Income Q3 2023 · Sep 30, 2022 −$603.36K
Net Income Q3 2023 · Sep 30, 2022 −$5.54M
Net Income Q3 2023 · Jun 30, 2022 −$2.53M
Net Income Q3 2023 · Mar 31, 2022 −$2.41M
Operating Income Q3 2023 · Sep 30, 2023 −$472.8K
Operating Income Q3 2023 · Sep 30, 2023 −$2.13M
Operating Income Q3 2023 · Sep 30, 2022 −$496.78K
Operating Income Q3 2023 · Sep 30, 2022 −$2.78M
Gross Profit Q3 2023 · Sep 30, 2023 $693
Gross Profit Q3 2023 · Sep 30, 2023 $129.44K
Gross Profit Q3 2023 · Sep 30, 2022 $6.93K
Gross Profit Q3 2023 · Sep 30, 2022 $8.77K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $827
Cost Of Revenue Q3 2023 · Sep 30, 2023 $4.82K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $4.03K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $5.12K
Revenue Q3 2023 · Sep 30, 2023 $1.52K
Revenue Q3 2023 · Sep 30, 2023 $134.26K
Revenue Q3 2023 · Sep 30, 2022 $10.96K
Revenue Q3 2023 · Sep 30, 2022 $13.89K